(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-HVEGFR2

Em AnáliseInvention PatentPCT · CN2022086525

Application data

Number

112023018537

Type

Invention Patent

Filing

04/13/2022

Publication

10/31/2023

PCT

CN2022086525

Progress at the INPI

  1. Filing04/13/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 04/13/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/31/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SUZHOU TRANSCENTA THERAPEUTICS CO., LTD.

CN

Inventors

H. L. (pessoa física)

CN

H. G. (pessoa física)

CN

X. Q. (pessoa física)

CN

Z. L. (pessoa física)

CN

Technical data

Priority claims

CN

PCT/CN2021/087278 · 04/14/2021

Abstract

ANTICORPOS ANTI-HVEGFR2. A presente invenção refere-se a anticorpos anti-hVEGFR2 ou fragmentos de ligação ao antígeno dos mesmos, polinucleotídeos isolados que codificam os mesmos, composições farmacêuticas compreendendo os mesmos e os usos dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

10/31/2023

RPI 2756

Alteração de dados cadastrais

#1.1

09/26/2023

RPI 2751

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.